CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)
 
     
 
 
 
Afexa Life Sciences Incorporated Company Snapshot
Business Description:
Afexa Life Sciences Incorporated operates in the Pharmaceutical preparations sector. Afexa Life Sciences Inc. (Afexa) is a life sciences and technology company. The Company is engaged primarily in the research, development and commercialization of natural medicines for health maintenance and disease prevention. It has developed and commercialized a technology, known as ChemBioPrint, which it used to discover and two-dimensionally standardize natural health products. Its product includes COLD-FX, COLD-FX Extra, IMMUNITY-FX, REMEMBER-FX, MEMORY-FX and CELL-FX. Its COLD-FX is designed to aid in the prevention and relief of colds and flu by strengthening the immune system. IMMUNITY-FX is consisted of a special formulation to help the immune system fight germs and pathogens that are foreign to the body. Its REMEMBER-FX product is sold in Canada to help restore mental alertness or wakefulness when experiencing fatigue or drowsiness. CELL-FX is a natural health product designed to help relieve symptoms of bone and joint pain and to help in the formation of connective tissue. In our complete report available for purchase the company is compared to: AEterna Zentaris Incorporated, Cardiome Pharma Corp. and QLT Inc..
   
   
 
  Stock Performance Chart for Afexa Life Sciences Incorporated
 
  Stock Data: Recent Stock Performance:
  Current Price (12/9/2011): .84
(Figures in Canadian Dollars)
1 Week 0.0%   13 Weeks 0.0%  
4 Weeks 15.1%   52 Weeks 68.0%  
 
Afexa Life Sciences Incorporated Key Data:
  Ticker: FXA Country: CANADA
  Exchanges: TOR Major Industry: Drugs, Cosmetics & Health Care
    Sub Industry: Ethical Drug Manufacturers
  2011 Sales 39,596,000
(Year Ending Jan 2012).
Employees: 126
  Currency: Canadian Dollars Market Cap: N/A
  Fiscal Yr Ends: March Shares Outstanding: N/A
  Share Type: Common Closely Held Shares: N/A
 
 
Featured Products and Services
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.